← Back to All Filings

ISRG Exec Sells $17.3M in Stock via 10b5-1 Plan, Exercises Options

Low SignificanceOctober 27, 2025 at 4:35:44 PM EDT

INTUITIVE SURGICAL INC

$ISRG4CIK: 0001035267

Subscribe to track ISRG

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

ISRG Exec Sells $17.3M in Stock via 10b5-1 Plan

Company: INTUITIVE SURGICAL INC (ISRG) Form: 4 | Filed: 2025-10-27 Significance: Low

Insider: GUTHART GARY S Title: Executive Chair of the Board | Relationship: Director, Officer

Transaction: • Type: Exercise-and-Sell • Exercised: 36,000 shares @ $109.49 • Sold: 31,600 shares @ ~$547.44 avg. • Sale Value: $17,299,192 • Direct Owned After: 27,027 shares

Key Insight: The sale, representing less than 0.01% of market cap, was conducted under a pre-arranged 10b5-1 trading plan. This is a routine transaction for liquidity and tax purposes, not a change in outlook.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: INTUITIVE SURGICAL INC (ISRG)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Executive Chair conducted a planned, multi-part transaction involving an option exercise and subsequent sales totaling $17.3M under a Rule 10b5-1 plan. The transaction size is immaterial relative to the company's market capitalization.
  • Market Impact: Neutral. The pre-planned nature (10b5-1) and the small size of the sale relative to the company's scale suggest minimal market impact.

Company Information

FieldValue
CompanyINTUITIVE SURGICAL INC
Ticker SymbolISRG
CIK0001035267
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies

Insider Information

FieldValue
NameGUTHART GARY S
CIK0001280628
Title/PositionExecutive Chair of the Board
RelationshipDirector, Officer

Transaction Details

This filing reports a series of related transactions on the same day: an option exercise followed by three separate sales.

Aggregate Sale Transaction:

FieldValue
Form Type4
Transaction Date2025-10-24
Transaction CodeS (Sale) & M (Option Exercise)
Security TypeCommon Stock
Shares Involved31,600 shares sold
Average Price Per Share~$547.44 (weighted average)
Total Value$17,299,192
Shares Owned After27,027 (Directly)
Ownership TypeDirect & Indirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Total Sale Value$17,299,192
% of Market Cap0.009%
Total Shares Sold31,600
% of Shares Outstanding0.009%
Post-Transaction OwnershipThe insider's direct holdings increased to 27,027 shares. Total indirect holdings are over 1.2 million shares.
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a mega-cap company with a market capitalization of $193.74 billion, a $17.3 million sale is financially insignificant, representing less than one-hundredth of one percent of the company's value.
  • Ownership Concentration: The 31,600 shares sold represent a very small fraction of the insider's total beneficial ownership, which exceeds 1.2 million shares held across direct and indirect accounts (trusts). The sale does not materially decrease his stake in the company.
  • Dilution Impact: The transaction involved exercising existing options, not issuing new ones. The 36,000 shares acquired from the exercise represent a negligible 0.01% of total shares outstanding, posing no meaningful dilution risk to shareholders.
  • Transaction Significance: The transaction is classified as 'Low' significance. Both the value as a percentage of market cap (0.009%) and shares as a percentage of outstanding (0.009%) are well below the thresholds for moderate or high significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The sale is a routine 'exercise-and-sell' transaction, often used by executives for financial planning, tax obligations, and portfolio diversification. The execution under a 10b5-1 plan signals that the trade was not based on any immediate, non-public information.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size is too small to impact the daily trading volume of a large, liquid stock like ISRG.
  • Sentiment Indicator: Neutral. Sophisticated investors will recognize this as a planned liquidity event by a long-term insider, not a bearish signal on the company's future prospects.

Investment Insights

Positive Market Indicators

  • The insider's direct holdings increased as a result of the net transaction (36,000 shares acquired vs. 31,600 sold).
  • The insider maintains a very large ownership stake, indicating continued alignment with shareholder interests.

Risk Factors

  • No significant risk factors are indicated by this filing. The sale is routine and non-indicative of a change in the insider's confidence.

Key Takeaways

  1. Immaterial Sale Size: The $17.3M sale is insignificant for a company of ISRG's scale.
  2. Pre-Planned Transaction: The sale was executed under a Rule 10b5-1 trading plan, removing speculation about its timing.
  3. Net Share Increase: The insider exercised more shares than he sold, resulting in a net increase in his direct holdings, which can be viewed as a positive.

Additional Context

Transaction Notes

  • Special Circumstances: As noted in Footnote F1, all transactions were made pursuant to a Rule 10b5-1 trading plan established prior to the trade date. This provides a strong affirmative defense against accusations of trading on inside information.
Topics:#SECFiling#InsiderTrading#ISRG#IntuitiveSurgical#Form4#StockMarket#10b51#ExecutiveChair#MedTech#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.